Riskpilot← Back to searchSign inGet full accessElmFa Medical AB
ABActiveOrg 5591603898Björnidegränd 103Medical specialists activities · NACE 8622Est. 20180 employees
Revenue 2025
SEK 294K
-66% vs 2024
EBITDA margin
60.2%
-75% vs 2024
Equity ratio
88.2%
Financial strength
Net profit 2025
SEK 151K
-73% vs 2024
| Revenue | SEK 294K | -66% |
| EBITDA | SEK 177K | -75% |
| Net profit | SEK 151K | -73% |
| Total assets | SEK 1,1M | -20% |
| Equity | SEK 969K | +6% |
| Employees | 0 | — |
Legal name
ElmFa Medical AB
Org number
5591603898
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
28 maj 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva hälso- och sjukvård i form av uthyrning av läkartjänst inom öppenvård, primärvård och inom slutenvård. Bolaget skall även bedriva estetiska behandlingar och inköp av sjukvårdsartiklar och läkemedel samt därmed förenlig verksamhet. Föremålet för verksamheten skall även vara IT tjänster och friskvård.
Address
Björnidegränd 103
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 500 | 407 | 658 | 871 | 294 |
| Staff expenses | — | −18 | −0 | −18 | −14 |
| EBITDA | 375 | 324 | 503 | 714 | 177 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 375 | 324 | 503 | 714 | 177 |
| Net financials | −3 | −0 | 1 | 1 | 18 |
| Profit before tax | 502 | 249 | 503 | 714 | 195 |
| Tax | −108 | −51 | −103 | −152 | −43 |
| Net profit | 394 | 198 | 400 | 563 | 151 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 755 | 572 | 790 | 1 376 | 1 099 |
| Equity | 477 | 315 | 534 | 917 | 969 |
| Long-term debt | 0 | 24 | 0 | — | — |
| Short-term debt | 278 | 234 | 255 | 459 | 130 |
| Total debt | 278 | 258 | 255 | 459 | 130 |
EBITDA margin
60.2%
This company
15.8%
Market median
+281% vs market
20212025
Equity ratio
88.2%
This company
38.2%
Market median
+131% vs market
20212025
Return on equity
15.6%
This company
18.4%
Market median
+15% vs market
20212025
Net profit margin
51.5%
This company
8.1%
Market median
+536% vs market
20212025
Asset turnover
0.27×
This company
1.12×
Market median
-76% vs market
20212025
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ElmFa Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Fatemeh Niknejad | Deputy Board Member | 0 companies |
| Elmira Farhoudfar | Board of Directors | 0 companies |